CrossfireX, the first-person shooter game coming to Xbox One, Xbox Series S and X consoles, will officially debut on February 10th, 2022 as revealed during The Game Awards 2021.
The game is unique in that while its multiplayer was crafted by franchise owner Smilegate Entertainment, the single player portion has been developed by Remedy, the acclaimed Finnish studio known for the first two Max Payne installments, Alan Wake, Quantum Break, and most recently Control.
Featuring two single-player campaign Operations being developed by Remedy Entertainment (Control, Alan Wake, Max Payne), CrossfireX will immerse players in a sprawling global conflict between Global Risk and Black List, two of the world’s most formidable private military factions. Global Risk’s agents use advanced technology to fight for order and security, while Black List’s mercenaries fight to disrupt their efforts.
CrossfireX features a full suite of diverse multiplayer modes designed by Smilegate Entertainment.
Take a look at the fresh new trailer below.
About the author: With over two decades of experience in gaming journalism, Alessio Palumbo has led the gaming vertical at Wccftech since August 2015. He started working at a young age for Italian websites like Everyeye.it, Gamestar.it, Nextgame.it, and Multiplayer.it before kickstarting the indie English-language publication Worlds Factory as its founder and Editor in Chief. In the last decade, he has coordinated the overall output of Wccftech's gaming section, managed PR relations, assigned reviews, produced daily news coverage, edited gaming content as needed, and delivered game reviews. Arguably, his trademark content is the long series of exclusive developer interviews that have been cited by Wikipedia and by the biggest news media and gaming publications. His passion for technology also makes him knowledgeable when it comes to gaming hardware and tech. His favorite genres include RPGs, MMORPGs, and action/adventure games.
Follow Wccftech on Google to get more of our news coverage in your feeds.
